http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22319637

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 242
issn 1549-9634
issueIdentifier 1
pageRange 231-242
publicationName Nanomedicine : nanotechnology, biology, and medicine
startingPage 231
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c088f179f38d9527ce440d93f36e7f47
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0e1255f679d9f479dd13e792d585f344
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d293c46021a0e85fb539d3919c28feeb
bibliographicCitation Capo A, Sepe R, Pellino G, Milone M, Malapelle U, Pellecchia S, Pepe F, Cacciola NA, Manigrasso M, Bruzzaniti S, Sciaudone G, De Palma GD, Galgani M, Selvaggi F, Troncone G, Fusco A, D'Auria S, Pallante P. Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. Nanomedicine: Nanotechnology, Biology and Medicine. 2019 Jan;15(1):231–42. doi: 10.1016/j.nano.2018.09.011.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5239bd0b24d59aadca012f86bf8a4d7a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6a57e07b8e5166422a408819f4ef64f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd9ed0031ad84c7bfa2cb4b00c44c129
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1547b8fe7746d5f0352ddf8388cb3a1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53211c4bc87aff12d44c4578b055e454
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25e83261084fb3894981619c195406e9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc047a6dbe5823711f94758bc12672e9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_350e1a927b6f9704da4cc13a2e882323
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b81d04a2ca4bb00dcfd94c416b7d989
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48adfc07c0b7860734dd95f839380eea
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0662535508d043fa8dca59dff67c4eb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11c813951b17a3d0b585ce782c8f871a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c62f7dc3a772eca82d6017cc76fae21
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_111be6936395d1adf9981a11f349d47c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1f057b59d9bf7b92740c9ee4f32baac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb40e8fddec0b73d479e51cdbb4c52f8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f34b022819de3628c75be9f2957661cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7341f3921e7de7d46e5604d8d39702c5
date 201901
identifier https://pubmed.ncbi.nlm.nih.gov/30308301
https://doi.org/10.1016/j.nano.2018.09.011
isPartOf https://portal.issn.org/resource/ISSN/1549-9634
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32817
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients
discusses http://id.nlm.nih.gov/mesh/M0018641
http://id.nlm.nih.gov/mesh/M0212171
http://id.nlm.nih.gov/mesh/M0022149
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015179Q000097
http://id.nlm.nih.gov/mesh/D036103Q000379
http://id.nlm.nih.gov/mesh/D011994Q000276
http://id.nlm.nih.gov/mesh/D025742Q000097
http://id.nlm.nih.gov/mesh/D015374Q000379
http://id.nlm.nih.gov/mesh/D014408Q000097
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015179Q000276
http://id.nlm.nih.gov/mesh/D020349
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D025742Q000276
http://id.nlm.nih.gov/mesh/D014408Q000276
http://id.nlm.nih.gov/mesh/D004797
http://id.nlm.nih.gov/mesh/D016022
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3159

Total number of triples: 57.